Hey Folks,
Most investors see TUTH and scroll right past — an OTC bulletin board stock with a market cap under $6 million and a ticker that looks like a typo. But Standard Dental Labs is quietly executing a roll-up strategy in one of the most fragmented industries in America: dental prosthetics.
The company has gone from a $236,000 annual revenue business to a $1.1 million+ annualized revenue operation in a single transaction — and it's not done yet. With a pipeline of five additional acquisitions and a freshly minted SEC-qualified Regulation A offering , Standard Dental Labs is building Florida's first scalable dental laboratory network from the ground up.
BREAKING (June 26, 2026): Standard Dental Labs executed a Letter of Intent to acquire another established dental laboratory in the Tampa Bay region , following last month's transformational BRLIT acquisition that increased the company's revenue base by more than 375%.
The Roll-Up Strategy: Building Florida's Dental Lab Network
The Problem: A Fragmented Industry
Florida's dental laboratory industry is composed largely of independently owned facilities, many of which are seeking succession and modernization solutions. These small shops — often family-run for decades — face mounting pressure from digital workflows, CAD/CAM technology, and consolidating dental service organizations on the customer side.
Standard Dental Labs offers these owners a structured pathway to transition while retaining participation in the company's broader growth through equity ownership and continued operational involvement.
The BRLIT Acquisition: A Transformational Catalyst
On May 6, 2026, Standard Dental Labs closed the acquisition of BRLIT Dental Laboratory of Sarasota, Florida — a nearly five-decade-old institution founded in 1977.
The numbers tell the story:
Metric | Pre-Acquisition | Post-Acquisition | Change |
|---|---|---|---|
Annual Revenue | ~$236,000 | > $1.1 million | +375%+ |
BRLIT Contribution | — | ~$886,000 | — |
Operational Footprint | Limited | Florida's Gulf Coast | Major Expansion |
Source:
"This acquisition represents a transformational step for Standard Dental Labs. BRLIT is an exceptionally well-established laboratory with a multi-generational history, an excellent reputation, and deep customer relationships throughout the region."
— James Brooks, CEO of Standard Dental Labs
Under the terms of the transaction, BRLIT continues operating in tandem with Standard Dental Labs' platform, with key personnel remaining actively involved in day-to-day operations.
The Dream Dentistry Labs Acquisition
Prior to BRLIT, Standard Dental Labs signed a binding agreement on November 4, 2025 to acquire Dream Dentistry Labs, LLC of Clearwater, Florida.
Dream Dentistry employs five experienced technicians and is on pace to exceed $1 million in revenue for 2025. The lab specializes in digital implant design, full-arch restorations, chairside conversions, and CAD/CAM workflows.
The acquisition is structured with a combination of cash and performance-based shares vesting over a two-year period contingent upon defined operational and revenue milestones.
The Acquisition Pipeline: Five More in the Works
Standard Dental Labs has been transparent about its growth trajectory. In October 2025, the company announced it had begun preparing financial and operational materials for auditor review in connection with another Florida dental laboratory acquisition — the first of five new acquisitions currently in the pipeline.
"Following our acquisition of Prime Dental Labs, we're now preparing materials for our next acquisition — the second in a growing pipeline."
— James Brooks, CEO of Standard Dental Labs
The company is currently in active negotiations with four other dental laboratories across Central Florida, currently under exclusivity rights pursuant to previously announced letters of intent.
The Corporate Rebrand: From CSSI to TUTH
Standard Dental Labs hasn't always been Standard Dental Labs. On March 13, 2025, the company completed a comprehensive corporate overhaul:
Name Change: From Costas, Inc. to Standard Dental Labs Inc.
Ticker Change: From "CSSI" to "TUTH"
Reverse Stock Split: 20:1 ratio, effective March 13, 2025
New CUSIP Number: 22160A305
Pre-split shares outstanding: ~572,206,363
Post-split shares outstanding: ~28,610,318
"This marks an exciting milestone for Standard Dental Labs. The FINRA approval and stock split reflect our commitment to advancing SDL's market position while continuing to execute our strategy of acquiring and integrating dental labs."
— James Brooks, CEO of Standard Dental Labs
The Capital Story: SEC-Qualified Regulation A Offering
On August 18, 2025, Standard Dental Labs received SEC qualification for a Regulation A offering.
What This Means
Regulation A (often called "Reg A+") allows companies to offer and sell shares to both accredited and non-accredited investors, expanding access to capital beyond traditional institutional channels.
For a micro-cap OTC company, this is significant:
Broader investor base — retail investors can participate directly
Lower cost of capital than traditional PIPE or private placements
Increased visibility and credibility with the SEC's blessing
The EMAC Capital Partnership
On March 23, 2026, Standard Dental Labs entered into an agreement with EMAC Capital LLC to provide capital markets advisory services. This partnership suggests the company is preparing for additional capital formation to fuel its acquisition pipeline.
Board & Leadership Developments
Brendan Cummins Appointed to Board
On April 20, 2026, SDL announced the appointment of Brendan Cummins to the board of directors. Mr. Cummins brings extensive experience in capital markets over a 35-year career.
Executive Leadership
James D. Brooks — President and Chief Executive Officer
The company has a lean operation with just 3 employees as of December 31, 2025 — down 25% from the previous year
The Financial Picture: Pre-Revenue Scale-Up
Revenue Transformation
Period | Revenue | Notes |
|---|---|---|
Pre-BRLIT Annual | ~$236,000 | Base business |
Post-BRLIT Annualized | > $1.1 million | +375% increase |
Q4 2025 | $36,490 | -49.17% YoY |
TTM Revenue | $236,230 | -16.8% |
Sources:
Profitability & Balance Sheet
Metric | Value |
|---|---|
Net Income (TTM) | -$1.11 million |
EPS | -$0.03 |
Total Shareholder Equity | -$3.2 million |
Total Debt | $2.3 million |
Debt-to-Equity Ratio | -70.9% |
Total Assets | $59,300 |
Total Liabilities | $3.3 million |
The company is technically insolvent on a book value basis, with negative shareholder equity of -$3.2 million. This is not uncommon for early-stage roll-ups that are debt-financing acquisitions, but it's a critical risk factor.
Stock & Valuation Snapshot
Metric | Value |
|---|---|
Stock Price | ~$0.11 – $0.21 |
Market Cap | $5.97 million |
Shares Outstanding | ~39.83 million (post-split adjusted) |
52-Week Change | +104.32% |
Beta (5Y) | 7.68 (extreme volatility) |
Price-to-Sales Ratio | 16.9x |
Peer Average P/S | 2.1x |
Employees | 3 |
Note: The 52-week change of +104% reflects the post-reverse-split adjusted price. The stock has been volatile, trading between $0.11 and $0.21 in recent months.
TUTH trades on the OTCQB under the ticker symbol "TUTH".
The Bull Case in 3 Parts
1. The Roll-Up Strategy Is Working — And Accelerating
Standard Dental Labs went from $236K in annual revenue to $1.1M+ in a single acquisition. The BRLIT deal closed on May 6, 2026. The Dream Dentistry deal is in the pipeline. The Tampa Bay LOI was signed on June 26, 2026. And there are five more acquisitions in the pipeline.
This is a company executing. Each acquisition adds revenue, customers, and technical capabilities. The compounding effect could be significant.
2. The Industry Is Perfectly Positioned for Consolidation
Florida's dental laboratory industry is highly fragmented. Independent owners are aging out. Digital workflows are creating economies of scale. Dental service organizations (DSOs) are consolidating on the customer side, creating pressure on small labs to keep up.
Standard Dental Labs offers a solution: transition, equity participation, and access to centralized management, operational efficiencies, and advanced technology.
3. The Reg A+ Offering Opens a New Capital Channel
The SEC-qualified Regulation A offering allows SDL to raise capital from both accredited and non-accredited investors. This is a massive advantage for an OTC micro-cap that would otherwise struggle to access retail capital. Combined with the EMAC Capital partnership, the company appears to be positioning for accelerated growth.
Critical Risk Disclosures
OTCQB Listing: TUTH trades on the OTCQB — not a major exchange. This means lower liquidity, wider spreads, less regulatory oversight, and limited institutional coverage. The stock is highly illiquid.
Negative Shareholder Equity: The company has -$3.2 million in shareholder equity and $3.3 million in liabilities against just $59,300 in assets. This is a balance sheet in distress. The company is technically insolvent.
Tiny Revenue Base: Even after the BRLIT acquisition, annualized revenue is just $1.1 million. The company is still pre-profit with a -$1.11 million net loss.
Extreme Dilution Risk: The company has 2 billion authorized shares. While only ~39.83 million are currently outstanding, the authorized share count is massive — creating significant future dilution risk if the company issues more shares to fund acquisitions.
Execution Risk: The company has signed LOIs and binding agreements, but there is no guarantee that the Tampa Bay acquisition will close, that the five pipeline acquisitions will materialize, or that integration will be successful.
Forward-Looking Statements: All statements regarding revenue growth, future acquisitions, integration efforts, and long-term shareholder value are forward-looking and subject to significant risks and uncertainties.
Competition: The dental laboratory consolidation space is attracting larger, better-capitalized players. SDL's small size puts it at a disadvantage.
Nasdaq Uplisting Unlikely: With a market cap under $6 million and negative equity, an uplisting to Nasdaq is not imminent — and may never happen.
The Bottom Line
TUTH is a high-risk, speculative micro-cap roll-up attempting to consolidate Florida's fragmented dental laboratory industry. The company has executed one transformational acquisition (BRLIT, +375% revenue), signed a binding agreement (Dream Dentistry), executed an LOI (Tampa Bay), and has five more in the pipeline.
The roll-up thesis is compelling — a fragmented industry, aging owners, and a consolidator with a disciplined acquisition strategy. The SEC-qualified Reg A offering provides a capital channel that most OTC micro-caps lack.
But the balance sheet is distressed, the revenue base is tiny, the stock is highly illiquid, and dilution risk is massive. This is a binary bet on execution — if the acquisitions close and integrate successfully, the upside could be significant. If they don't, the downside is zero.
Most investors see the TUTH ticker and scroll past. But sometimes, the companies rolling up the most fragmented industries — with the most skepticism — are exactly where the next asymmetric move begins.
This newsletter is for informational purposes only and does not constitute investment advice. Always conduct your own due diligence before making investment decisions. TUTH is an OTC stock with extreme volatility and liquidity risk.
Sources
https://www.nasdaq.com/press-release/standard-dental-labs-inc-otcmkts-tuth-announces-name-change-ticker-symbol-change-and
https://www.globenewswire.com/news-release/2026/06/26/3318200/0/en/Standard-Dental-Labs-Inc-Signs-Letter-of-Intent-to-Acquire-Additional-Dental-Laboratory-in-the-Tampa-Bay-Region.html
https://www.manilatimes.net/2026/05/07/tmt-newswire/globenewswire/standard-dental-labs-inc-closes-acquisition-of-brlit-dental-laboratory-increasing-revenue-base-by-more-than-375/2338595
https://www.dentistrytoday.com/standard-dental-labs-prepares-for-next-acquisition/
https://markets.businessinsider.com/news/stocks/standard-dental-labs-signs-binding-agreement-to-acquire-dream-dentistry-labs-llc-strengthening-central-florida-operations-1035494853
https://stockanalysis.com/stocks/tuth/
https://www.otcmarkets.com/stock/TUTH/overview
